铜绿假单胞菌延伸因子Tu(EF-Tu)是一种具有免疫原性的保护性蛋白抗原
铜绿假单胞菌是医院获得性肺炎和囊性纤维化慢性肺部感染的重要病原体,天然耐药且无可用疫苗。本研究显示铜绿假单胞菌EF-Tu在人体具有免疫原性,小鼠免疫重组EF-Tu后可产生免疫应答,免疫小鼠受保护免于后续铜绿假单胞菌肺炎,将疫苗抗血清转移至 naïve 小鼠可减少定植。
要点
- 铜绿假单胞菌EF-Tu在人体具有免疫原性。
- 小鼠免疫重组铜绿假单胞菌EF-Tu后可产生免疫应答。
- 免疫小鼠受保护免于后续铜绿假单胞菌肺炎,疫苗抗血清转移可减少定植。
核心结论
- 研究结果支持将EF-Tu作为抗铜绿假单胞菌新疫苗候选抗原加以考虑。
研究设计与样本
- 本研究评估铜绿假单胞菌EF-Tu在人体中的免疫原性,并在小鼠中免疫重组铜绿假单胞菌EF-Tu后评估免疫应答及对后续铜绿假单胞菌肺炎的保护作用。
主要发现
- 铜绿假单胞菌EF-Tu在人体具有免疫原性。
- 小鼠免疫重组铜绿假单胞菌EF-Tu后可产生免疫应答。
- 免疫小鼠受保护免于后续铜绿假单胞菌肺炎。
- 将疫苗抗血清转移至naïve小鼠可减少定植。
关键数值与推荐
- 铜绿假单胞菌可导致高达20%的医院获得性肺炎。
- 尽管抗菌治疗和医院护理有所改善,铜绿假单胞菌菌血症和肺炎仍在约30%的病例中致命。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pseudomonas aeruginosa is a Gram-negative, opportunistic pathogen that infects immunocompromised individuals, especially in the hospital setting. This bacterium is an important pathogen in people with weakened immune systems, injuries, and other underlying physiologic dysfunctions. P. aeruginosa is responsible for up to 20 % of all hospital-acquired pneumonias. It is one of the major causes of nosocomial infections and has been noted to be one of the most common bacteria co-infecting patients with COVID-19 or causing super-infections following COVID-19 infections. Despite improvements in antimicrobial therapy and hospital care, P. aeruginosa bacteremia and pneumonia remain fatal in about 30 % of cases. P. aeruginosa is also the leading cause of chronic life-threatening lung infections in cystic fibrosis patients. This bacterium is naturally antibiotic resistant, and infections are notoriously difficult to treat once established, with no vaccine available. We have previously shown that elongation factor-Tu (EF-Tu), a protein best known for its role in protein synthesis, is surface exposed on P. aeruginosa. As this protein is highly expressed, evolutionally conserved, and essential, we hypothesized it would make a good vaccine target. In this study, we found that P. aeruginosa EF-Tu is immunogenic in people, and that mice can develop an immune response following immunization with recombinant P. aeruginosa EF-Tu. Furthermore, immunized mice were protected from subsequent P. aeruginosa pneumonia and transfer of this vaccine antisera to naïve mice resulted in decreased colonization. Altogether these findings support the consideration of EF-Tu as a new vaccine candidate against P. aeruginosa.
引用
- Moustafa DA, Lou E, Schafer-Kestenman ME, et al. Pseudomonas aeruginosa elongation factor-Tu (EF-Tu) is an immunogenic protective protein antigen. Vaccine. 2024. PMID: 39476472. doi:10.1016/j.vaccine.2024.126476
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。